Our focus in on Life Sciences. We specialize in services that support Bio/Pharmaceutical, and Combination Device companies. Our clients range from venture-backed to global public companies.
Since 2015 we have supported more than 40 companies with services including regulatory strategy, clinical developmentpipeline and portfolio optimization, M&A due diligence and compliance and training. We can help companies, scientifically, strategically or operationally  to:
  • Navigate complex and frequently changing regulations
  • Engage and interact with regulatory agencies
  • Guide companies through the entire drug development process
  • Support your due diligence
  • Assess organizational effectiveness



Sharon W. Ayd, Ph.D., MBA

Founder &  Chief Executive Officer

Sharon Ayd, Ph.D., MBA, is a senior, international operations executive with proven leadership in creating and operationally implementing corporate strategy for highly competitive multi-national Biopharmaceutical companies.


Dr. Ayd is the former Global Vice President, Innovation & Development of Fresenius-Kabi (DAX:FRE) a $7B global healthcare company based in Frankfurt, Germany. Previously, Sharon was Global Vice President, Research & Development of Hospira/Pfizer (NYSE:HSP) a $4.5B provider of pharmaceuticals and medical devices.

Dr. Ayd also has experience in venture-backed biopharmaceutical companies. She was a founding member of Transcend Therapeutics (TSND:NASDAQ), Chief Operations Officer at Advanced Life Sciences (ADLS:NASDAQ) and Chief Science Officer at Pinnacle Biologics (private).

Dr. Ayd’s international experience includes orchestrating international submissions simultaneously to multiple regulatory agencies such as FDA (US), EMA (EU), MHRA (UK), Health Canada (Canada) and TGA (Australia). She is recognized for her contributions resulting in ~100 global drug approvals (A/NDA, sNDA, 505(b)(2)).
A network of hand picked, highly qualified subject matter experts is available as needed to tackle a challenge when a team of individuals is called for. This approach allows us to "right size" the resources assigned to your project as peaks and valleys demand.
Ayd BioPharma Consulting Group, LLC also partners with select Alliance Partners. They must meet our strict embodiment for ethics, quality, use fiscally sound business practice and possess deep subject matter expertise.

© 2023 by James Consulting. Proudly created with Wix.com